CISS revenueFY2025$34.76M
- FY YoY
- -17.8%
CISS revenue was $34.76M for fiscal 2025 (ended Dec 31, 2025), down 17.8% from fiscal 2024.
For fiscal 2025 (ended Dec 31, 2025), C3is Inc. reported $34.76M of revenue and $10.47M of net income.
CISS revenue was $34.76M for fiscal 2025 (ended Dec 31, 2025), down 17.8% from fiscal 2024.
CISS net income was $10.47M for fiscal 2025 (ended Dec 31, 2025), compared with -$2.75M in fiscal 2024.
CISS diluted EPS was $3.98 for fiscal 2025 (ended Dec 31, 2025).
CISS free cash flow was $3.84M for fiscal 2025 (ended Dec 31, 2025), down 83.6% from fiscal 2024.
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 |
|---|---|---|---|
| Revenue | $34.76M | $42.30M | $28.74M |
| Operating income | $1.36M | $10.06M | $10.43M |
| Net income | $10.47M | -$2.75M | $9.29M |
| EPS, basic | $46.50 | -$351.58 | $47133.25 |
| EPS, diluted | $3.98 | -$351.58 | $18911.99 |
| Diluted shares | 350,055 | 23,007 | 487 |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 |
|---|---|---|---|
| Cash and equivalents | $616.6K | $4.64M | $695.3K |
| Inventory | $1.31M | $884.1K | $689.3K |
| Current assets | $20.84M | $16.34M | $20.31M |
| Total assets | $98.49M | $100.49M | $95.47M |
| Current liabilities | $3.36M | $18.69M | $39.93M |
| Total liabilities | $3.39M | $29.13M | $39.93M |
| Shareholders' equity | $95.10M | $71.36M | $55.54M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 |
|---|---|---|---|
| Operating cash flow | $4.00M | $24.98M | $5.64M |
| Capital expenditures | $161.9K | $1.62M | $4.30M |
| Free cash flow | $3.84M | $23.35M | $1.34M |
| Investing cash flow | -$6.54M | -$1.36M | -$12.43M |
| Financing cash flow | -$1.49M | -$19.67M | $7.48M |
| Stock-based compensation | $375.2K | $337.9K | $37.6K |
Source: XBRL data C3is Inc. files with the SEC, latest filing dated Apr 22, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
Per-share figures and share counts are restated for stock splits the filings show: 1-for-15, first reported Apr 28, 2025; 1-for-20, first reported Apr 22, 2026.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
Foreign private issuers file annual reports with the SEC, so there are no quarterly statements here.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| CISS | $34.76M | -17.8% | $10.47M | 30.1% | $7.4M |
| GD | $56.52B | +9.7% | $4.66B | 8.2% | $97.84B |
| RCL | $19.13B | +9.7% | $4.55B | 23.8% | $90.13B |
| CCL | $27.59B | +5.2% | $3.14B | 11.4% | $41.43B |
| VIK | $6.50B | +21.9% | $1.15B | 17.7% | $38.86B |
| BIP | $23.10B | +9.8% | $2.53B | 11.0% | $18.16B |
| HII | $13.53B | +12.6% | $733.00M | 5.4% | $11.99B |
| FRO | $1.97B | -8.8% | $379.08M | 19.2% | $9.86B |
| NCLH | $10.16B | +4.9% | $832.94M | 8.2% | $8.46B |